Abstract
We investigated the short-term bronchodilator effects of RPL554 (an inhaled dual phosphodiesterase 3 and 4 inhibitor) combined with other bronchodilators in chronic obstructive pulmonary disease patients with reversibility (>150 mL to short-acting bronchodilators).Study 1 was a six-way, placebo-controlled crossover study (n=36) with single doses of RPL554 (6 mg), salbutamol (200 µg), ipratropium (40 µg), RPL554 (6 mg)+salbutamol (200 µg), RPL554 (6 mg)+ipratropium (40 µg) or placebo. Study 2 was a three-way crossover study (n=30) of tiotropium (18 µg) combined with RPL554 (1.5 or 6 mg) or placebo for 3 days. Forced expiratory volume in 1 s (FEV1), lung volumes and specific airway conductance (sGaw) were measured.In study 1, peak FEV1 change compared with placebo was similar with RPL554, ipratropium and salbutamol (mean 223, 199 and 187 mL, respectively). The peak FEV1 was higher for RPL554+ipratropium versus ipratropium (mean difference 94 mL; p<0.0001) and RPL554+salbutamol versus salbutamol (mean difference 108 mL; p<0.0001). In study 2 (day 3), both RPL554 doses caused greater peak FEV1 effects than placebo. The average FEV1(0-12 h) increase was greater with RPL554 6 mg only versus placebo (mean difference 65 mL; p=0.0009). ...Continue Reading
References
Aug 1, 1992·British Journal of Pharmacology·J de BoerC D Nicholson
Aug 1, 1996·British Journal of Pharmacology·E NalineJ A Karlsson
May 13, 1998·British Journal of Clinical Pharmacology·P G BardinS T Holgate
Sep 3, 1999·American Journal of Respiratory and Critical Care Medicine·S MyouT Matsuda
Jan 5, 2001·British Journal of Pharmacology·D T SchmidtK F Rabe
Aug 2, 2005·The European Respiratory Journal·M R MillerUNKNOWN ATS/ERS Task Force
May 10, 2006·The Journal of Pharmacology and Experimental Therapeutics·Victoria Boswell-SmithClive P Page
Jun 11, 2009·British Journal of Pharmacology·Katharine H Banner, Neil J Press
Sep 1, 2009·Lancet·Leonardo M FabbriUNKNOWN M2-127 and M2-128 study groups
Jan 29, 2011·Respiratory Research·Stephen I RennardFernando J Martinez
Jun 23, 2011·Handbook of Experimental Pharmacology·C P Page, D Spina
Jun 15, 2013·The Journal of Pharmacology and Experimental Therapeutics·Luigino CalzettaMaria Gabriella Matera
Jan 17, 2014·The Lancet. Respiratory Medicine·Lui G FranciosiClive P Page
Feb 13, 2014·Basic & Clinical Pharmacology & Toxicology·Katharine H Abbott-Banner, Clive P Page
Mar 1, 1993·The European Respiratory Journal·P H QuanjerJ C Yernault
Aug 28, 2014·Expert Review of Respiratory Medicine·Daniel LangerDenis E O'Donnell
Apr 23, 2015·Pulmonary Pharmacology & Therapeutics·Luigino CalzettaMaria Gabriella Matera
May 14, 2016·British Journal of Pharmacology·R Venkatasamy, D Spina
Citations
Nov 6, 2018·The European Respiratory Journal·Mario Cazzola, Clive Page
Mar 7, 2020·The Korean Journal of Internal Medicine·Chin Kook Rhee, Deog Kyeom Kim
May 14, 2020·Expert Opinion on Investigational Drugs·Luigino CalzettaPaola Rogliani
Dec 25, 2019·European Respiratory Review : an Official Journal of the European Respiratory Society·Mario CazzolaMaria Gabriella Matera
Dec 19, 2019·Pharmacological Reviews·M G MateraM Cazzola
May 22, 2020·Frontiers in Pharmacology·Marta JoskovaSona Franova
Apr 1, 2020·Frontiers in Pharmacology·Jonathan E Phillips
May 14, 2020·Journal of Personalized Medicine·Sean D McCarthyBrendan D Higgins
Sep 29, 2020·International Journal of Chronic Obstructive Pulmonary Disease·Henrik WatzDave Singh
Jan 27, 2019·Expert Opinion on Investigational Drugs·Polyxeni NtontsiGeorgios Hillas
Feb 12, 2020·Respiratory Research·Dave SinghBrian T Maurer
Sep 3, 2019·Expert Opinion on Investigational Drugs·Mario CazzolaMaria Gabriella Matera
Oct 6, 2020·The Journal of Pharmacology and Experimental Therapeutics·Mark TurnerJohn W Hanrahan
Nov 12, 2020·American Journal of Physiology. Lung Cellular and Molecular Physiology·Jennifer M K NguyenVenkataramana K Sidhaye
Dec 18, 2020·Current Opinion in Pharmacology·Maria Gabriella MateraClive Page
Apr 30, 2021·International Journal of Chronic Obstructive Pulmonary Disease·Gary T FergusonKathleen Rickard
Jun 11, 2021·ERJ Open Research·Chris KyriakopoulosKonstantinos Kostikas
Aug 26, 2021·International Journal of Chronic Obstructive Pulmonary Disease·Clémence MartinNicolas Roche
Nov 4, 2021·Drugs·Dave SinghAlexander G Mathioudakis